Historical record - last NADAC publication: 4/20/2016
Product Information
FENTANYL CITRATE OTFC 400 MCG is a generic product labeled by Teva Pharmaceuticals USA Inc., priced at $9.8957 per EA under NDC 00093786665. Its NADAC has been published 67 times since Jan 6, 2016.
The High Outlier badge above means this manufacturer's average price in the Fentanyl Citrate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
400 ug/1
Manufacturer
Teva Pharmaceuticals USA Inc.NDC
00093786665
Classification
Generic
Dosage Form
LOZENGE
Route
ORAL; TRANSMUCOSAL
Last Updated
4/20/2016
Active Ingredients
FENTANYL CITRATEApproval Type
Authorized Generic (NDA)
FDA Application
NDA020747On Market Since
12/8/2015
Pharmacological Classes
Price Statistics
The NADAC for FENTANYL CITRATE OTFC 400 MCG has been published 67 times since Jan 6, 2016, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $9.8957 per EA |
|---|---|
| All-time high | $9.8957 (May 10, 2017) |
| All-time low | $9.8021 (Jan 6, 2016) |
| Median price | $9.8957 |
| Average price | $9.8803 |
| Largest weekly change | +1.0% (Apr 20, 2016) |
| Weeks tracked | 67 |
| Tracking since | Jan 6, 2016 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Fentanyl Citrate market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of FENTANYL CITRATE OTFC 400 MCG?
The current National Average Drug Acquisition Cost (NADAC) for FENTANYL CITRATE OTFC 400 MCG, manufactured by Teva Pharmaceuticals USA Inc., is $9.8957 per EA (NDC 00093786665), effective May 10, 2017.
How has the price of FENTANYL CITRATE OTFC 400 MCG changed over time?
Over the history we have for it, the NADAC for FENTANYL CITRATE OTFC 400 MCG has held within roughly two percent of its current level. It has been tracked across 67 weekly CMS publications since Jan 6, 2016.
What are the highest and lowest recorded NADAC prices for FENTANYL CITRATE OTFC 400 MCG?
Since Jan 6, 2016, the NADAC for FENTANYL CITRATE OTFC 400 MCG has ranged from a low of $9.8021 (Jan 6, 2016) to a high of $9.8957 (May 10, 2017), with a median of $9.8957 per EA.
Are there cheaper alternatives to FENTANYL CITRATE OTFC 400 MCG?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of FENTANYL CITRATE OTFC 400 MCG, so no direct lower-cost alternative is listed.
Who manufactures FENTANYL CITRATE OTFC 400 MCG?
FENTANYL CITRATE OTFC 400 MCG (NDC 00093786665) is labeled by Teva Pharmaceuticals USA Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification